Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorVastra Gotaland Region
About this trial
This randomized controlled trial aim to determine the impact on renal function after treatment for infrarenal abdominal aortic aneurysm (AAA) with stentgrafts either with active supra- or infrarenal fixation.
Eligibility criteria
Qualifiers
Willing and able to provide written informed consent
Meet criteria for non-ruptured infrarenal/iliac aneurysm
Suitable anatomy for treatment with an approved device (CE-marked) stentgraft according to the manufacturers' instructions for use for AAA.
Accepted for treatment with endovascular aortic repair (EVAR) by the participating vascular center.
Disqualifiers
Ongoing or planned dialysis
AAA treatment requiring stents or stentgrafts in renal and/or visceral arteries
Inability to independently complete HRQoL questionnaires due to language barriers
Anatomical preconditions that do not allow both types of fixation to be used interchangeably, i.e. very advanced suprarenal tortuosity (>60 degrees), advanced suprarenal dilatation or infrarenal thrombus >25% of circumference.
Trial design
Treatments tested in this trial
- Stentgraft
Treatment groups
252 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov